ADVANCED PHARMACOLOGY MIDTERM
EXAM (2025) Actual Exam Questions and
Answers A+ Graded
Nurse .practitioner .prescriptive .authority .is .regulated .by:
a. The .National .Council .of .Sate .Board .of .Nursing
b. The .State .Board .of .Nursing .for .each .state
c. The .U. .S. .Drug .Enforcement .Administration
d. The .State .Board .of .Pharmacy .- .ANSWER- .b. .The .State .Board .of
.Nursing .for .each .state
Eight .Information .needed .for .the .prescription .- .ANSWER- .1. .Date .of
.prescribing;
2. Name .of .patient(s);
,3. Prescriber's .name;
4. Name, .strength, .and .dosage .of .drug .or .device;
5. Number .of .refills, .if .applicable;
6. Quantity .prescribed .in .weight, .volume, .or .number .of .units;
7. An .indication .of .whether .generic .substitution .has .been .authorized .by
.the .prescriber;
8. Any .change .or .alteration .made .to .the .prescription .dispensed .on
.contact .with .the .prescriber .must .show .a .clear .audit .trail.
Three .additional .required .information .for .controlled .substances .-
.ANSWER- .1. .Address .of .the .prescriber .and .patient;
2. .The .prescriber's .DEA .number;
3 .Controlled .prescriptions .shall .also .comply .with .all .requirements .of
.federal .and .state .controlled .substance .laws.
Who .oversees .the .APRN's .prescribing .of .controlled .substances?
a. The .pharmaceutical .board .of .the .state
b. The .federal .government .(DEA)
c. The .practice .protocols .of .the .hospital
d. Practice .agreements .- .ANSWER- .b. .The .federal .government .(DEA)
The .USFDA .regulates:
a. Prescribing .of .drugs .by .medical .doctors .and .nurse .practitioners
,b. The .official .labeling .for .all .prescription .and .over-the-counter .drugs
c. Off-label .recommendations .for .prescribing
d. Pharmaceutical .educational .offering .- .ANSWER- .b. .The .official
.labeling .for .all .prescription .and .over-the-counter .drugs
Medication .agreements .or ."Pain .Medication .Contracts" .are
.recommended .to .be .used:
a. Universally .for .all .prescribing .for .chronic .pain
b. For .patients .who .have .repeated .requests .for .pain .medication
c. When .you .suspect .a .patient .is .exhibiting .drug-seeking .behavior
d. For .patients .with .pain .associated .with .malignancy .- .ANSWER- .a.
.Universally .for .all .prescribing .for .chronic .pain
Anaphylactic .shock .is .a:
a. Type .I .reaction, .called .immediate .hypersensitivity .reaction
b. Type .II .reaction, .called .cytotoxic .hypersensitivity .reaction
c. Type .III .reaction, .called .immune .complex .hypersensitivity
d. Type .IV .reaction, .called .delayed .hypersensitivity .reaction .-
ANSWER- .a. .Type .I .reaction, .called .immediate .hypersensitivity .reaction
The .role .of .the .nurse .practitioner .with .regards .to .herbal .medication .is .to:
, a. Maintain .competence .in .the .prescribing .of .common .herbal .remedies.
b. Recommend .common .over-the-counter .herbs .to .patients.
c. Educate .patients .and .guide .them .to .appropriate .sources .of .care.
d. Encourage .patients .to .not .use .herbal .therapy .due .to .the .documented
.dangers. .- .ANSWER- .c. .Educate .patients .and .guide .them .to .appropriate
.sources .of .care.
Prescribing .for .women .during .their .childbearing .years .requires .constant
.awareness .of .the .possibility .of:
a. High .risk .for .developmental .disorders .in .their .infants
b. Decreased .risk .for .abuse .during .this .time
c. Possible .unknown .pregnancy
d. Possibility .of .drug .allergies .- .ANSWER- .c. .Possible .unknown
.pregnancy
Dysmenorrhea .is .one .of .the .most .common .gynecological .complaints .in
.young .women. .The .first-line .of .drug .treatment .for .this .disorder .is:
a. Oral .contraceptive .pills
b. Caffeine
c. NSAIDs
d. Aspirin .- .ANSWER- .c. .NSAIDs
A .medication .review .of .an .elderly .person's .medications .involves:
EXAM (2025) Actual Exam Questions and
Answers A+ Graded
Nurse .practitioner .prescriptive .authority .is .regulated .by:
a. The .National .Council .of .Sate .Board .of .Nursing
b. The .State .Board .of .Nursing .for .each .state
c. The .U. .S. .Drug .Enforcement .Administration
d. The .State .Board .of .Pharmacy .- .ANSWER- .b. .The .State .Board .of
.Nursing .for .each .state
Eight .Information .needed .for .the .prescription .- .ANSWER- .1. .Date .of
.prescribing;
2. Name .of .patient(s);
,3. Prescriber's .name;
4. Name, .strength, .and .dosage .of .drug .or .device;
5. Number .of .refills, .if .applicable;
6. Quantity .prescribed .in .weight, .volume, .or .number .of .units;
7. An .indication .of .whether .generic .substitution .has .been .authorized .by
.the .prescriber;
8. Any .change .or .alteration .made .to .the .prescription .dispensed .on
.contact .with .the .prescriber .must .show .a .clear .audit .trail.
Three .additional .required .information .for .controlled .substances .-
.ANSWER- .1. .Address .of .the .prescriber .and .patient;
2. .The .prescriber's .DEA .number;
3 .Controlled .prescriptions .shall .also .comply .with .all .requirements .of
.federal .and .state .controlled .substance .laws.
Who .oversees .the .APRN's .prescribing .of .controlled .substances?
a. The .pharmaceutical .board .of .the .state
b. The .federal .government .(DEA)
c. The .practice .protocols .of .the .hospital
d. Practice .agreements .- .ANSWER- .b. .The .federal .government .(DEA)
The .USFDA .regulates:
a. Prescribing .of .drugs .by .medical .doctors .and .nurse .practitioners
,b. The .official .labeling .for .all .prescription .and .over-the-counter .drugs
c. Off-label .recommendations .for .prescribing
d. Pharmaceutical .educational .offering .- .ANSWER- .b. .The .official
.labeling .for .all .prescription .and .over-the-counter .drugs
Medication .agreements .or ."Pain .Medication .Contracts" .are
.recommended .to .be .used:
a. Universally .for .all .prescribing .for .chronic .pain
b. For .patients .who .have .repeated .requests .for .pain .medication
c. When .you .suspect .a .patient .is .exhibiting .drug-seeking .behavior
d. For .patients .with .pain .associated .with .malignancy .- .ANSWER- .a.
.Universally .for .all .prescribing .for .chronic .pain
Anaphylactic .shock .is .a:
a. Type .I .reaction, .called .immediate .hypersensitivity .reaction
b. Type .II .reaction, .called .cytotoxic .hypersensitivity .reaction
c. Type .III .reaction, .called .immune .complex .hypersensitivity
d. Type .IV .reaction, .called .delayed .hypersensitivity .reaction .-
ANSWER- .a. .Type .I .reaction, .called .immediate .hypersensitivity .reaction
The .role .of .the .nurse .practitioner .with .regards .to .herbal .medication .is .to:
, a. Maintain .competence .in .the .prescribing .of .common .herbal .remedies.
b. Recommend .common .over-the-counter .herbs .to .patients.
c. Educate .patients .and .guide .them .to .appropriate .sources .of .care.
d. Encourage .patients .to .not .use .herbal .therapy .due .to .the .documented
.dangers. .- .ANSWER- .c. .Educate .patients .and .guide .them .to .appropriate
.sources .of .care.
Prescribing .for .women .during .their .childbearing .years .requires .constant
.awareness .of .the .possibility .of:
a. High .risk .for .developmental .disorders .in .their .infants
b. Decreased .risk .for .abuse .during .this .time
c. Possible .unknown .pregnancy
d. Possibility .of .drug .allergies .- .ANSWER- .c. .Possible .unknown
.pregnancy
Dysmenorrhea .is .one .of .the .most .common .gynecological .complaints .in
.young .women. .The .first-line .of .drug .treatment .for .this .disorder .is:
a. Oral .contraceptive .pills
b. Caffeine
c. NSAIDs
d. Aspirin .- .ANSWER- .c. .NSAIDs
A .medication .review .of .an .elderly .person's .medications .involves:
